Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes-Reference-Cited by-同舟云学术

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes

Published:2019-12-18 Issue: Volume:6 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Mika Thomas,Strate Katharina,Ladigan Swetlana,Aigner Clemens,Schlegel Uwe,Tischoff Iris,Tischer-Zimmermann Sabine,Eiz-Vesper Britta,Maecker-Kolhoff Britta,Schroers Roland

Publisher

Frontiers Media SA

Subject

General Medicine

Reference13 articles.

1. Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities;Al Hamed;Bone Marrow Transplant.,2019

2. Post-transplantation lymphoproliferative disorders in adults;Dierickx;N Engl J Med.,2018

3. EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era;Fox;Bone Marrow Transplant.,2014

4. Management of post-transplant lymphoproliferative disorders;DeStefano;Br J Haematol.,2018

5. Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders;Vase;Leukemia Lymphoma.,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-07-03

2. Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in post-transplant lymphoproliferative disorder;2024-05-13

3. Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type;Transplantation Reviews;2024-04

4. Immunologic Therapies in Development for EBV Driven Lymphoid Malignancies;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

5. Assessment of Serum Soluble CD30 Levels in Pediatric Kidney Transplant Recipients;South East European Journal of Immunology;2023-11-30